PAR

Par Drugs And Chemicals Limited

· Unclassified
₹ CrorePeersBALAXICROWNSTEELCITYHINDCONLATTEYSHECPROJECTAIROLAMGROBTEA
Comp Set
In ₹ Crore except Per Share
Latest Annual
PAR
FY26
BALAXI
FY26
CROWN
FY26
STEELCITY
FY26
Peer
Median
Valuation — at last close
P/E88.81×14.99×9.56×14.99×
P/B0.51×1.73×1.00×1.00×
EV/EBITDA19.78×9.11×8.61×9.11×
Market Cap₹127 Cr₹134 Cr₹138 Cr₹134 Cr
Growth
Revenue CAGR 3Y2.68%-7.05%27.25%4.48%4.48% -40%
Revenue CAGR 5Y3.15%3.53%3.34%
Net Income CAGR 3Y4.97%-68.64%31.51%8.43%8.43% -41%
Revenue YoY (latest Q)20.10%14.05%29.27%28.51%28.51% -29%
Net Income YoY (latest Q)41.60%347.57%4.51%66.71%66.71% -38%
Profitability
EBITDA Margin16.53%3.16%52.72%26.84%26.84% -38%
Net Income Margin12.65%0.52%22.33%22.95%22.33% -43%
Return on Common Equity11.71%0.57%11.46%10.47%10.47% +12%
Return on Capital Employed11.63%2.15%10.40%11.22%10.40% +12%
Return on Assets10.15%0.42%4.13%6.02%4.13% +146%
Credit & Quality
Total Debt/Equity0.00×0.22×0.73×0.07×0.22× -100%
Interest Coverage105.48×1.63×3.06×17.51×3.06× +3347%
Scale — latest FY
Revenue / Total Income₹104 Cr₹270 Cr₹39.7 Cr₹62.3 Cr₹62.3 Cr +66%
Net Income₹13.1 Cr₹1.4 Cr₹8.9 Cr₹14.3 Cr₹8.9 Cr +48%
Total Assets₹129 Cr₹337 Cr₹215 Cr₹237 Cr₹237 Cr -46%
EPS₹10.65₹0.26₹7.72₹9.57₹7.72 +38%
Book Value per Share₹91.01₹45.12₹66.76₹91.35₹66.76 +36%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.